Enhancement of Ad5-Trail Cytotoxicity Against Renal Cell Carcinoma With Histone Deacetylase Inhibitors

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700939
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Combining Histone Deacetylase Inhibitors With MDA-7/IL-24 Enhances Killing of Renal Carcinoma Cells

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2013English

Manipulation of B-Cell Responses With Histone Deacetylase Inhibitors

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2015English

Inhibitors of Histone-Deacetylase

Journal of Applied Biomedicine
GeneticsMolecular BiologyPharmacologyBiochemistryBiological SciencesToxicologyMedicineAgriculturalNeurosciencePharmaceutics
2005English

Pharmacogenomics and Histone Deacetylase Inhibitors

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2016English

Histone Deacetylase Inhibitors From Burkholderia Thailandensis

Journal of Natural Products
Organic ChemistryMolecular MedicinePharmacologyComplementaryPharmaceutical ScienceAnalytical ChemistryAlternative MedicineDrug Discovery
2011English

Histone Deacetylase Inhibitors Synergizes With Catalytic Inhibitors of EZH2 to Exhibit Anti-Tumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Histone Deacetylase Inhibitors as Cancer Therapeutics

Annals of Translational Medicine
Medicine
2016English

A Potentiated Cooperation of Carbonic Anhydrase IX and Histone Deacetylase Inhibitors Against Cancer

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2019English

Histone Deacetylase Inhibitors in Cancer Therapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy